Disc Medicine Initiates Phase 1b/2 Clinical Study of DISC-0974 in Myelofibrosis Patients with Severe Anemia

Open-label study will evaluate the potential for DISC-0974, a first-in-class, anti-HJV (hemojuvelin) monoclonal antibody to improve anemia in myel...

Related Keywords

United States ,Cambridge ,Cambridgeshire ,United Kingdom ,Texas ,Srdan Verstovsek ,John Quisel ,University Of Texas Md Anderson Cancer Center ,Chief Executive Officer ,Janus Kinase ,Expansion Stage ,About Disc ,